Challenges with Diagnosing and Managing Sepsis in Older Adults.

Abstract:

:Sepsis in older adults has many challenges that affect rate of septic diagnosis, treatment, and monitoring parameters. Numerous age-related changes and comorbidities contribute to increased risk of infections in older adults, but also atypical symptomatology that delays diagnosis. Due to various pharmacokinetic/pharmacodynamic changes in the older adult, medications are absorbed, metabolized, and eliminated at different rates as compared to younger adults, which increases risk of adverse drug reactions due to use of drug therapy needed for sepsis management. This review provides information to aid in diagnosis and offers recommendations for monitoring and treating sepsis in the older adult population.

authors

Clifford KM,Dy-Boarman EA,Haase KK,Maxvill K,Pass SE,Alvarez CA

doi

10.1586/14787210.2016.1135052

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

231-41

issue

2

eissn

1478-7210

issn

1744-8336

journal_volume

14

pub_type

杂志文章,评审
  • New targets in the search for preventive and therapeutic agents for botulism.

    abstract::Botulism is a severe neuroparalytic disease resulting from exposure to one of the most poisonous toxins to humans. Because of this high potency and the use of toxins as biological weapons, botulism is a public health concern and each case represents an emergency. Current therapy involves respiratory supportive care an...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.945917

    authors: Anniballi F,Lonati D,Fiore A,Auricchio B,De Medici D,Locatelli CA

    更新日期:2014-09-01 00:00:00

  • Post-exposure prophylaxis for HIV infection.

    abstract::Post-exposure prophylaxis (PEP) with antiretrovirals is now widely used worldwide after either occupational contact (with blood or another blood-containing fluid), or nonoccupational contact (mainly sexual or injection-drug use). It is assumed to reduce the risk of HIV transmission by at least 80%, although its effica...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.20

    authors: Rey D

    更新日期:2011-04-01 00:00:00

  • Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health.

    abstract:INTRODUCTION:Monkeypox is a re-emerging viral zoonosis that occurs naturally in heavily forested regions of West and Central Africa. Inter-human transmission of monkeypox virus, although limited, drives outbreaks, particularly in household and health-care settings. But the available evidence suggests that without repea...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2019.1567330

    authors: Reynolds MG,Doty JB,McCollum AM,Olson VA,Nakazawa Y

    更新日期:2019-02-01 00:00:00

  • Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.

    abstract:BACKGROUND:Neuraminidase inhibitors (NAIs) reduce influenza symptoms but clear evidence of relationships between viral titer reduction and symptom alleviation is lacking. This open-label, randomized study evaluated differences in viral dynamics between NAIs, and relationships between viral dynamics and influenza sympto...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1080/14787210.2018.1421945

    authors: Hirotsu N,Saisho Y,Hasegawa T,Shishido T

    更新日期:2018-02-01 00:00:00

  • Diagnosis of hantavirus infection in humans.

    abstract::Rodent-borne hantaviruses (family Bunyaviridae, genus Hantavirus) cause hantavirus pulmonary syndrome in the Americas and hemorrhagic fever with renal syndrome in Europe and Asia. The viruses are transmitted to humans mainly by inhalation of virus-contaminated aerosols of rodent excreta and secreta. Classic clinical h...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2015.1047825

    authors: Mattar S,Guzmán C,Figueiredo LT

    更新日期:2015-08-01 00:00:00

  • Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.

    abstract::Invasive aspergillosis (IA) is currently an important cause of morbidity and mortality in hematopoietic stem cell transplant and solid organ transplant recipients. A high index of suspicion and careful clinical and radiological examinations are the keys to identifying infected patients early. Chest computerized axial ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.13

    authors: Salman N,Törün SH,Budan B,Somer A

    更新日期:2011-03-01 00:00:00

  • Risk factors for hepatitis E virus infection and disease.

    abstract::Hepatitis E, caused by hepatitis E virus, is a disease of global significance, causing 20 million infections each year. Genotypes 1 and 2 have vastly different epidemiological patterns from genotypes 3 and 4. In genotype 1 and 2 endemic areas, most infections and illness occur in persons 15-30 years of age, with pregn...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2015.981158

    authors: Kmush BL,Nelson KE,Labrique AB

    更新日期:2015-01-01 00:00:00

  • Commercially available assays for multiplex detection of alpha human papillomaviruses.

    abstract::Five main groups of commercial assays for the multiplex detection of alpha human papillomaviruses (HPVs) are currently available. DNA-based screening assays, which test for the presence of 13-14 HPVs without determination of HPV type, have been the standard for HPV detection in the last decade. Assays that combine tes...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.10.104

    authors: Poljak M,Kocjan BJ

    更新日期:2010-10-01 00:00:00

  • Drug combinations for HIV: what's new?

    abstract::Since the advent of combined antiretroviral therapy there have been reductions in mortality and morbidity from HIV, transforming the disease into a chronic medical condition where newly diagnosed individuals can expect to live a near-normal life expectancy. When choosing therapy, probably the most important considerat...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.125

    authors: Scourfield A,Waters L,Nelson M

    更新日期:2011-11-01 00:00:00

  • Treatment of chronic hepatitis B: focus on telbivudine.

    abstract::Chronic hepatitis B is a worldwide health problem. Research interests have focused on the development of potent and safe antiviral agents with low resistance rates. Among these, telbivudine is an oral nucleoside analogue with specific activity against hepatitis B virus DNA polymerase. Various prospective, randomized c...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.09.6

    authors: Lui YY,Chan HL

    更新日期:2009-04-01 00:00:00

  • Syphilis incidence in men who have sex with men with human immunodeficiency virus comorbidity and the importance of integrating sexually transmitted infection prevention into HIV care.

    abstract:INTRODUCTION:Syphilis continues to be a growing epidemic among men who have sex with men (MSM), particularly for those living with the human immunodeficiency virus (HIV). In 2016, MSM accounted for 80% of primary and secondary syphilis diagnoses in men in the United States; almost half of who were also HIV-infected. Th...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1446828

    authors: Refugio ON,Klausner JD

    更新日期:2018-04-01 00:00:00

  • A cross-sectional study evaluating the knowledge and beliefs about, and the use of antibiotics amongst Malaysian university students.

    abstract:BACKGROUND:The introduction of antibiotics into modern medicine has changed clinical care by saving millions of lives. However, misuse of antibiotics has led to their benefits being overshadowed by the development of antimicrobial resistance. AIMS OF STUDY:This study aimed to assess university students' knowledge and ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2019.1581607

    authors: Haque M,Rahman NAA,McKimm J,Binti Abdullah SL,Islam MZ,Zulkifli Z,Saidin NB,Azhar NIK,Binti Lutfi SNN,Binti Othman NSA

    更新日期:2019-04-01 00:00:00

  • Immunomodulatory therapy in yeast infections.

    abstract::Invasive yeast infections are a significant cause of morbidity and mortality in patients with defective immune response, such as those with cancer-related immunosuppression, organ transplantation or other immunodeficiencies, and neonates. Hospitalization in the intensive care unit may increase the risk for such infect...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.1.129

    authors: Garbino J,Katragkou A,Roilides E

    更新日期:2007-02-01 00:00:00

  • Risk of infection associated with anti-TNF-α therapy.

    abstract:INTRODUCTION:The advent, more than two decades ago, of monoclonal antibodies and soluble receptors targeting tumor necrosis factor (TNF)-α has revolutionized the therapeutic approach to otherwise difficult-to-treat autoimmune and inflammatory diseases. However, due to the pleiotropic functions played by this pro-inflam...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1544490

    authors: Fernández-Ruiz M,Aguado JM

    更新日期:2018-12-01 00:00:00

  • Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections.

    abstract::Lopinavir is a protease inhibitor (PI) for the treatment of HIV infection that was specifically designed to overcome the shortcomings of earlier agents in this class. It is the only PI coformulated with ritonavir, whose pharmacological boosting effect results in a highly potent, well-tolerated, clinically effective an...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.1.13

    authors: Tan D,Walmsley S

    更新日期:2007-02-01 00:00:00

  • 6th meeting of the World Society for Pediatric Infectious Diseases.

    abstract::The 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), which was recently held in Buenos Aires, Argentina, between 18 and 22 November 2009, attracted 2401 attendees from 90 countries representing six continents. The WSPID, founded in 1994 by Professor Saldana Gonzalez of the Mexican Ped...

    journal_title:Expert review of anti-infective therapy

    pub_type:

    doi:10.1586/eri.10.6

    authors: Falade AG

    更新日期:2010-03-01 00:00:00

  • The history and evolution of immigration medical screening for tuberculosis.

    abstract::Identifying and managing TB in immigrating populations has been an important aspect of immigration health for over a century, with the primary aim being protecting the host population by preventing the import of communicable diseases carried by the arriving migrants. This review describes the history and development o...

    journal_title:Expert review of anti-infective therapy

    pub_type: 历史文章,杂志文章

    doi:10.1586/eri.12.168

    authors: Dara M,Gushulak BD,Posey DL,Zellweger JP,Migliori GB

    更新日期:2013-02-01 00:00:00

  • Development of treatment strategies to combat Ebola and Marburg viruses.

    abstract::Ebola and Marburg viruses are emerging/re-emerging pathogens that pose a significant threat to human health. These naturally occurring viral infections frequently cause a lethal hemorrhagic fever in humans and nonhuman primates. The disastrous consequences of infection with these viruses have been pursued as potential...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.1.67

    authors: Paragas J,Geisbert TW

    更新日期:2006-02-01 00:00:00

  • Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis.

    abstract::Cryptosporidiosis, the disease caused by protozoa of the genus Cryptosporidium, represents a major public health problem in both developing and developed countries. The infection can be severe and life threatening among immunocompromised individuals, particularly in AIDS patients and in those with primary immunodefici...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.3.429

    authors: Cacciò SM,Pozio E

    更新日期:2006-06-01 00:00:00

  • Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

    abstract::The constant new emergence of life-threatening human respiratory viral pathogens presents new challenges to clinicians who are left with no available therapeutic interventions. Highly pathogenic strains of influenza A virus (IAV) share an enhanced capacity to propagate to the lower airways and paralyze alveolar macrop...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.966082

    authors: Coulombe F,Divangahi M

    更新日期:2014-11-01 00:00:00

  • Itraconazole (Sporanox) in superficial and systemic fungal infections.

    abstract::Itraconazole (Sporanox) is a triazole antifungal agent with a broad activity spectrum and favorable pharmacokinetic and safety profiles. Numerous clinical trials have established the efficacy and safety of itraconazole in the treatment of superficial fungal infections. In this field, full exploitation of its pharmacok...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.1.4.531

    authors: Caputo R

    更新日期:2003-12-01 00:00:00

  • Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.

    abstract::Cationic antimicrobial peptides are a novel type of antibiotic offering much potential in the treatment of microbial-related diseases. They offer many advantages for commercial development, including a broad spectrum of action and modest size. However, despite the identification or synthetic production of thousands of...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.6.951

    authors: Hale JD,Hancock RE

    更新日期:2007-12-01 00:00:00

  • Treatment of neurocysticercosis: is it beneficial?

    abstract::Neurocysticercosis is the most common parasitic disease of the CNS. Intracranial neurocysticercosis is classified into cerebral parenchymal and extraparenchymal forms (subarachnoidal and intraventricular). Current medical therapy for parenchymal and extraparenchymal neurocysticercosis invovles the use of anticysticerc...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1586/14787210.6.4.435

    authors: Garg RK

    更新日期:2008-08-01 00:00:00

  • Malaria in pregnancy: diagnosing infection and identifying fetal risk.

    abstract::Despite increased malaria control efforts, recent reports indicate that over 1.2 million deaths due to malaria occurred in 2010. Pregnant women represent a particularly vulnerable risk group as malaria infection can lead to life-threatening disease for the mother and fetus. With 125 million women at risk of malaria in...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.123

    authors: Conroy AL,McDonald CR,Kain KC

    更新日期:2012-11-01 00:00:00

  • Advances in the diagnosis and management of neurocysticercosis.

    abstract::Neurocysticercosis is the most common cause of late-onset epilepsy in developing countries. The larval stage of Taenia solium is the causative agent of the disease. Recent advances in neuroimaging and serologic diagnostic techniques have led to increased recognition of its importance, but its pathogenesis is just begi...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.6.1051

    authors: Serpa JA,Yancey LS,White AC Jr

    更新日期:2006-12-01 00:00:00

  • Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.

    abstract::Hospital infection due to multidrug-resistant Gram-positive bacteria may often represent a life-threatening challenge; thus, to appropriately combat them, clinicians should be confident and systematically apply several important pharmacodynamic concepts. The concept of 'correct antibiotic treatment' should include, in...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.2.255

    authors: Pea F,Viale P

    更新日期:2007-04-01 00:00:00

  • Role of GB virus C in modulating HIV disease.

    abstract::GB virus C (GBV-C) is a member of the Flaviviridae family and the most closely related human virus to HCV. However, GBV-C does not replicate in hepatocytes, but rather in lymphocytes. GBV-C has a worldwide distribution and is transmitted sexually, parenterally and through mother-to-child transmission. Thus, co-infecti...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.37

    authors: Schwarze-Zander C,Blackard JT,Rockstroh JK

    更新日期:2012-05-01 00:00:00

  • Diagnosis and management of Lyme neuroborreliosis.

    abstract:INTRODUCTION:The nervous system is involved in 10-15% of patients infected with B. burgdorferi, B. afzelii and B. garinii. This review will address widespread misconceptions about the clinical phenomenology, diagnostic approach and response to treatment of neuroborreliosis. Areas covered: Improvements in diagnostic tes...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1417836

    authors: Halperin JJ

    更新日期:2018-01-01 00:00:00

  • Prognostic markers of pediatric meningococcal sepsis.

    abstract::Having available tools to determine the prognosis of pediatric meningococcal sepsis at admission to the Intensive Care Unit or during the course of the disease constitutes a clinical necessity. Recently, new readily measurable circulating biomarkers have been described as an additional tool for severity classification...

    journal_title:Expert review of anti-infective therapy

    pub_type: 社论

    doi:10.1586/14787210.2014.945431

    authors: Briassoulis G,Galani A

    更新日期:2014-09-01 00:00:00

  • Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor.

    abstract::The development of HIV-1 integrase strand transfer inhibitors (INSTIs) has been a major therapeutic breakthrough in the management of HIV-1 infection. The first HIV-1 integrase inhibitor, raltegravir, was licensed in 2007 and was subsequently approved for use in treatment-naive patients. Since then, newer members of t...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.157

    authors: Lampiris HW

    更新日期:2012-01-01 00:00:00